CD69 and neoplasm: Consistent with the earlier findings, Rag2−/−‐OT1‐iHPC‐treated mice had infiltrating effector T cells (CD44high CD62Llow CD69+ CD25+) in the tumour and memory T cells (CD44high CD62Lhigh CD69− CD25−) in the spleen (Figure 5D).